Browsing: Multimedia

What’s scarier than ghosts and goblins? How about measles, unaffordable dental care, and an insurance claim denied by artificial intelligence?

Bill McAdams, a 45-year-old travel nurse from Holiday, Florida, was uninsured last year when he experienced a stroke. He hadn’t been able to afford his agency’s health plan, which would have cost $3,600 monthly to cover him and his wife. The hospital that treated him sent him a bill for $93,000.

Calif. — Ulises Hernandez has had health coverage through Medicaid for as long as he can remember. But he had never waited as long for care as he did in September after a dental crown slipped down his throat during a procedure. He spent eight hours in an emergency room waiting for care and more…

Refugees. Sex-trafficking victims. People fleeing war. They’re among the hundreds of thousands of immigrants living in the country legally who no longer qualify for Medicaid. The change, in effect since Oct. 1, is part of the 2025 Republican tax law, which cuts Medicaid spending by an estimated $900 billion through 2034.

The pitch behind California’s billionaire tax proposal is simple: Tax the richest residents in the nation’s wealthiest state to offset steep federal cuts to healthcare, food assistance, and education.

A cadre of elite techies, financiers, and high-level Trump administration officials have spent a year quietly charting an extraordinary and rapid campaign to persuade Americans to use apps and other artificial intelligence-powered tools to manage their healthcare and medical records.

When Lori Baute first learned about precautionary full-body MRI scans, she dismissed the idea.

Medications can snowball as we age. Pill organizers pile up. Prescriptions that are no longer necessary can mix with other drugs to create concerning side effects. 

Minn. — Floodwater seeped through the nursing home’s front door just before sunrise

Reports from a top artificial intelligence company that it stopped several attempted uses of its product that could assist in manufacturing a bioweapon caught the attention of lawmakers in Washington this week. But it is still unclear whether or when Congress will act to regulate the fast-moving industry — and the House has left town…